Psychedelic Funding in 2022

Rick Doblin – The Balance at MAPS Between Public Benefit and...

Expanding ketamine’s horizons for rare neurological disorders

Psychedelics in the Public Markets: 2022

The Psychedelic Value Chain

Psychedelics Weekly – Client Data Concerns in Oregon, Hopeful Legalization in...

Israel-Based Clearmind Successfully Completed Two R&D Projects With The Hebrew University...

Bexson Biomedical Issued USPTO Patent on Proprietary Formulation Technology, SEVALENT™

Revive Therapeutics Submits Updated Briefing Package in Support of Upcoming Type...

MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE...

Load more